Cost-effectiveness of oral hypoglycaemic agents for the treatment of type 2 diabetes mellitus

Author： Ward Alexandra   O’Brien Judith A   Salas Maribel  

Publisher： Informa Healthcare

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.6, Iss.4, 2005-04, pp. : 601-608

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cost Effectiveness of ACE Inhibitor Treatment for Patients with Type 1 Diabetes Mellitus

By Frederick B. Dong  

PharmacoEconomics, Vol. 22, Iss. 15, 2004-01 ,pp. : 1015-1027

Adis International

Access to resources Recommend Favorite

Oral Antidiabetic Agents: Current Role in Type 2 Diabetes Mellitus

By Krentz Andrew J.  

Drugs, Vol. 65, Iss. 3, 2005-01 ,pp. : 385-411

Adis International

Access to resources Recommend Favorite

Cost Effectiveness of Saxagliptin and Metformin versus Sulfonylurea and Metformin in the Treatment of Type 2 Diabetes Mellitus in Germany: A Cardiff Diabetes Model Analysis

By Erhardt Wilma  

Clinical Drug Investigation, Vol. 32, Iss. 3, 2012-03 ,pp. : 189-202

Adis International

Access to resources Recommend Favorite

Cost Effectiveness of Atorvastatin in Patients with Type 2 Diabetes Mellitus: A Pharmacoeconomic Analysis of the Collaborative Atorvastatin Diabetes Study in the Belgian Population

By Annemans L.   Marbaix S.  

Clinical Drug Investigation, Vol. 30, Iss. 2, 2010-02 ,pp. : 133-142

Adis International

Access to resources Recommend Favorite

A Review of Methods Used in Long-Term Cost-Effectiveness Models of Diabetes Mellitus Treatment

By Tarride Jean-Eric   Hopkins Robert   Blackhouse Gord   Bowen James M.   Bischof Matthias   >   O'Reilly Daria   Xie Feng   Goeree Ron  

PharmacoEconomics, Vol. 28, Iss. 4, 2010-04 ,pp. : 255-277

Adis International

Access to resources Recommend Favorite